Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs von Saravolatz, Louis D, Depcinski, Shawn, Sharma, Mamta

Volltext

Postantibiotic effect and postantibiotic sub‐MIC effect of LTX‐109 and mupirocin on Staphylococcus aureus blood isolates von Saravolatz, L.D., Pawlak, J., Martin, H., Saravolatz, S., Johnson, L., Wold, H., Husbyn, M., Olsen, W.M.

Volltext

Plazomicin: A New Aminoglycoside von Saravolatz, Louis D, Stein, Gary E

Volltext

Delafloxacin: A New Anti-methicillin-resistant Staphylococcus aureus Fluoroquinolone von Saravolatz, Louis D, Stein, Gary E

Volltext

Baloxavir: A Novel Antiviral Agent in the Treatment of Influenza von Abraham, George M, Morton, Jacob B, Saravolatz, Louis D

Volltext

In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid von Saravolatz, Louis D, Pawlak, Joan

Volltext

Predictors for Severe COVID-19 Infection von Bhargava, Ashish, Fukushima, Elisa Akagi, Levine, Miriam, Zhao, Wei, Tanveer, Farah, Szpunar, Susanna M, Saravolatz, Louis

Volltext

Oritavancin: A Long-Half-Life Lipoglycopeptide von Saravolatz, Louis D., Stein, Gary E.

Volltext

Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor von Sharma, Mamta, Saravolatz, Louis D

Volltext

Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid von Saravolatz, Louis D, Pawlak, Joan M, Wegner, Corinne

Volltext

The American Board of Internal Medicine's New Longitudinal Assessment Option and What It Means for Infectious Disease Specialists von Abraham, George M, Saravolatz, Louis D

Volltext

Ceftaroline-Heteroresistant Staphylococcus aureus von SARAVOLATZ, Stephanie N, MARTIN, Hayley, PAWLAK, Joan, JOHNSON, Leonard B, SARAVOLATZ, Louis D

Volltext

A comparison of coronavirus disease 2019 (COVID-19) versus influenza during the pandemic: Can we distinguish COVID-19 from flu? von Nichols, Lindsey K., Maki, Safa B., Szpunar, Susan M., Bhargava, Ashish, Saravolatz, Louis D.

Volltext

Partial Oral Therapy for Osteomyelitis and Endocarditis von Lauter, Carl B, Saravolatz, Louis D

Volltext

Rhodomyrtone: a new anti-Staphylococcus aureus agent against resistant strains von Saravolatz, Louis D, Pawlak, Joan

Volltext

Nitazoxanide: A New Thiazolide Antiparasitic Agent von Fox, LeAnne M., Saravolatz, Louis D.

Volltext

Ceftaroline: A Novel Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus aureus von Saravolatz, Louis D., Stein, Gary E., Johnson, Leonard B.

Volltext

In Vitro Activity of Retapamulin against Staphylococcus aureus Resistant to Various Antimicrobial Agents von SARAVOLATZ, Louis D, PAWLAK, Joan, SARAVOLATZ, Stephanie N, JOHNSON, Leonard B

Volltext

Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs von Saravolatz, Louis D, Depcinski, Shawn, Sharma, Mamta

Volltext

VISA–Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin von Saravolatz, Louis D., Pawlak, Joan

Volltext